Colgate-Palmolive (NYSE:CL) Stock Position Boosted by Dillon & Associates Inc.

Dillon & Associates Inc. boosted its stake in Colgate-Palmolive (NYSE:CL) by 0.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,104 shares of the company’s stock after buying an additional 150 shares during the period. Dillon & Associates Inc.’s holdings in Colgate-Palmolive were worth $2,830,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $26,000. Centricity Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $32,000. Briaud Financial Planning Inc bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $32,000. Finally, Wintrust Investments LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $33,000. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of several research reports. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a research note on Friday, March 14th. Finally, Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $101.72.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $90.30 on Monday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock’s 50-day moving average is $89.33 and its two-hundred day moving average is $94.07. The firm has a market cap of $73.28 billion, a P/E ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 EPS. Analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.30%. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. Colgate-Palmolive’s dividend payout ratio is 56.82%.

Colgate-Palmolive announced that its board has initiated a stock repurchase program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to buy up to 6.8% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board believes its stock is undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.